• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Axonics Buys Contura to Expand to Stress Urinary Incontinence

    Nurx Appoints Chief Medical Officer

    Median Technologies, UC San Diego to Partner on AI-Based Medical Imaging Technology

    Novel Heart Failure Treatment Technology Scores Positive Trial Results

    New COVID-19 Saliva Test Also Can Detect Variants and Flu Viruses
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Rethink Your Medtech ASC Strategy, Part 1

    Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

    Tips for Reigniting Your MDR/IVDR Preparation

    Three Major Innovation Opportunities for Biomedical Textiles

    Use Vertical Integration to Increase Productivity, Drive Innovation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Medbio LLC

    Concise Engineering

    MW Life Sciences

    maxon

    Creganna Medical, part of TE Connectivity
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Grant Funding Works and How It Can Help

    Refurbished Medical Equipment Testing and Certification Under the NEC

    Taking the First Step with Metal Components

    4 Trends Driving Medical Manufacturing in 2021

    Pioneering AI Solutions to Reinforce Healthcare Services
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Concise Engineering

    PTI Engineered Plastics Inc.

    Qosina Corp.

    MW Life Sciences

    FUTEK Advanced Sensor Technology Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA Approves First Ever CGM System with Implanted Sensor and Mobile App

    Senseonics' Eversense CGM system features a fully implantable sensor that can be worn for up to 90 days.

    FDA Approves First Ever CGM System with Implanted Sensor and Mobile App
    Eversense's smart transmitter sits over the sensor on the upper arm with a gentle silicone-based adhesive. It’s water-resistant, rechargeable, and can be removed and replaced without disturbing the sensor. The transmitter sends data to the Eversense Mobile App and provides on-body vibe alerts when glucose swings low or high. Image courtesy of Senseonics.
    Related CONTENT
    • January AI Raises $8.8 Million in New Funding
    • Medtronic Launches InPen with Real-Time Guardian Connect CGM Data
    • Dexcom, Eli Lilly Begin Program to Help Improve Diabetes Management
    • Senseonics Forges Strategic Collaboration With Ascensia Diabetes Care
    • Need for Better Glycemic Control During COVID-19 Fuels the CGM Market
    U.S. Food and Drug Administration06.22.18
    The U.S. Food and Drug Administration today approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people 18 years of age and older with diabetes. This is the first FDA-approved CGM system to include a fully implantable sensor to detect glucose, which can be worn for up to 90 days.
     
    “The FDA is committed to advancing novel products that leverage digital technology to improve patient care,” said FDA Commissioner Scott Gottlieb, M.D. “These technologies allow patients to gain better control over their health. This approval of a more seamless digital system that gives patients the ability to effectively manage a chronic disease like diabetes is a vivid illustration of the potential for these mobile platforms. The FDA is creating a new and more carefully tailored regulatory approach for software products, including mobile medical apps, that will enable efficient oversight of these digital technologies and maintain FDA’s gold standard for product review. We’re advancing a more modern approach for these products that’s carefully adapted to the unique characteristics of these opportunities.”
     
    People with diabetes either do not make enough insulin (type 1 diabetes) or cannot use insulin properly (type 2 diabetes). When the body does not have enough insulin, or cannot use it effectively, sugar builds up in the blood. High blood sugar levels can lead to heart disease, stroke, blindness, kidney failure and amputation of toes, feet or legs. Individuals living with diabetes must regularly monitor their glucose levels as part of the management of the disease. This includes making sure that diabetes management accessories, like most current glucose sensors, are replaced on a regular basis (generally, every seven days) to ensure that an overall CGM system is properly functioning.
     
    The Eversense CGM system uses a small sensor that is implanted just under the skin by a qualified health care provider during an outpatient procedure. After it is implanted, the sensor regularly measures glucose levels in adults with diabetes for up to 90 days. The implanted sensor works with a novel light-based technology to measure glucose levels and send information to a mobile app to alert users if glucose levels are too high (hyperglycemia) or too low (hypoglycemia). The sensor is coated with a fluorescent chemical which, when exposed to blood sugar, produces a small amount of light that is measured by the sensor. Every five minutes, measurements are sent to a compatible mobile device (e.g., smart phone or tablet) that is running a device-specific mobile app.
     
    The FDA evaluated clinical study data from 125 individuals aged 18 and older with diabetes and reviewed the device’s effectiveness by comparing readings obtained by the Eversense CGM system to those obtained by a laboratory-based glucose analyzer. The safety of the Eversense CGM system’s 90-day implantable sensor, and the procedure used to implant it, was also evaluated during the clinical studies. During these studies, the proportion of individuals experiencing a serious adverse event with the implanted sensor was less than 1 percent. The safety of this novel system will also be evaluated in a post-approval study. The FDA held an Advisory Committee meeting to provide an independent assessment of the safety and effectiveness of the Eversense CGM system. In an 8 to 0 vote, the committee recommended that the benefits of the Eversense CGM system outweigh the risks for patients with diabetes.
     
    Potential adverse effects related to insertion, removal and wear of the sensor include allergic reaction to adhesives, bleeding, bruising, infection, pain or discomfort, scarring or skin discoloration, sensor fracture during removal, skin inflammation, thinning, discoloration or redness. Other risks associated with use of the CGM system may include hypoglycemia or hyperglycemia in cases where information provided by the device is inaccurate or where alerts are missed.
     
    The FDA granted approval of the Eversense Continuous Glucose Monitoring System to Senseonics Inc.
    Related Searches
    • type 1
    • implant
    • type 1 diabetes
    • blood
    Related Knowledge Center
    • Patient Monitoring
    Suggested For You
    January AI Raises $8.8 Million in New Funding January AI Raises $8.8 Million in New Funding
    Medtronic Launches InPen with Real-Time Guardian Connect CGM Data Medtronic Launches InPen with Real-Time Guardian Connect CGM Data
    Dexcom, Eli Lilly Begin Program to Help Improve Diabetes Management Dexcom, Eli Lilly Begin Program to Help Improve Diabetes Management
    Senseonics Forges Strategic Collaboration With Ascensia Diabetes Care Senseonics Forges Strategic Collaboration With Ascensia Diabetes Care
    Need for Better Glycemic Control During COVID-19 Fuels the CGM Market Need for Better Glycemic Control During COVID-19 Fuels the CGM Market
    Studies Show Feasibility of a Minimally Invasive Approach to CGM in the Dermis Studies Show Feasibility of a Minimally Invasive Approach to CGM in the Dermis
    Senseonics Launches New Remote Monitoring App for Android Users Senseonics Launches New Remote Monitoring App for Android Users
    Tandem Diabetes Care Tandem Diabetes Care's t:slim X2 Insulin Pump with Basal-IQ Technology Wins FDA Nod
    Medtronic Introduces Food Data Analytics for iPro2 CGM Evaluation Medtronic Introduces Food Data Analytics for iPro2 CGM Evaluation
    Theranos Founder, Former Chief Operating Officer Charged With Alleged Wire Fraud Theranos Founder, Former Chief Operating Officer Charged With Alleged Wire Fraud
    Dexcom G6 CGM System Wins CE Mark Dexcom G6 CGM System Wins CE Mark
    Senseonics and Beta Bionics Partner to Develop the Bionic Pancreas System Senseonics and Beta Bionics Partner to Develop the Bionic Pancreas System
    Home Field Advantage: Examining Home Diagnostics for Chronic Disease Home Field Advantage: Examining Home Diagnostics for Chronic Disease
    FDA Initiates Device Development Challenge to Help Combat Opioid Crisis FDA Initiates Device Development Challenge to Help Combat Opioid Crisis
    FDA Seeks Permanent Injunctions Against Two Stem Cell Clinics FDA Seeks Permanent Injunctions Against Two Stem Cell Clinics

    Related Breaking News

    • Digital Health | Patient Monitoring
      Masimo Launches Tool to Support Reopening Schools, Businesses

      Masimo Launches Tool to Support Reopening Schools, Businesses

      Masimo SafetyNet-OPEN helps screen, trace, and manage users as they face COVID-19 and other infectious illnesses.
      Sam Brusco, Associate Editor 02.16.21

    • Digital Health | Patient Monitoring | Software & IT
      FDA OKs CLEW

      FDA OKs CLEW's AI-Based ICU Predictive Analytics Tech

      CLEWICU predicts hemodynamic instability in adult patients.
      Sam Brusco, Associate Editor 02.04.21

    • Digital Health | Patient Monitoring
      Philips Inks Connected Care Solutions Deal with 28-Hospital Dutch SAZ Group

      Philips Inks Connected Care Solutions Deal with 28-Hospital Dutch SAZ Group

      Different SAZ hospitals will start with Philips solutions for patient monitoring and self-management.
      Sam Brusco, Associate Editor 02.04.21


    • Patient Monitoring
      Hillrom Buys EarlySense

      Hillrom Buys EarlySense's Contact-Free Continuous Monitoring Tech

      EarlySense's contact-free continuous monitoring, analytics tech was integrated into the Centrella Smart+ med-surg bed.
      Sam Brusco, Associate Editor 02.01.21

    • Cardiovascular | Patient Monitoring
      Hillrom to Buy Bardy Diagnostics for $375M

      Hillrom to Buy Bardy Diagnostics for $375M

      Advances digital health offering with expansion into attractive ambulatory cardiac monitoring segment.
      PR Newswire 01.19.21

    • Patient Monitoring
      Valencell Launches Blood Pressure Monitoring Tech

      Valencell Launches Blood Pressure Monitoring Tech

      New technology can be built into a myriad of devices to provide accurate blood pressure readings.
      Valencell 01.13.21


    • Chronic Disease | Digital Health | Patient Monitoring
      Teladoc Health, Dexcom Launch CGM Tech, Personalized Insights for Type 2 Diabetes

      Teladoc Health, Dexcom Launch CGM Tech, Personalized Insights for Type 2 Diabetes

      CGM-powered insights offer complete health profile, recommendations that support ongoing diabetes management.
      GlobeNewswire 01.13.21

    • Patient Monitoring
      Unique Contact Lens Sensor System & Manufacturing Process Developed

      Unique Contact Lens Sensor System & Manufacturing Process Developed

      New multifunctional lens can provide diversified signals from eyes.
      Surrey University 01.12.21

    • Patient Monitoring
      Itamar Medical Acquires Spry Health Tech, Assets

      Itamar Medical Acquires Spry Health Tech, Assets

      Leverages Spry’s technology to bring to market first device for continuous remote patient monitoring of sleep apnea.
      GlobeNewswire 01.12.21


    • Patient Monitoring
      CES News: Philips Highlights Healthcare at Home

      CES News: Philips Highlights Healthcare at Home

      Participates in the first-ever all-digital CES 2021.
      Royal Philips 01.11.21

    • Patient Monitoring

      'Smart Ring' Could Spot a Fever Before You Feel It

      Advance could pave the way for early warning system on COVID-19 and flu using wearables.
      University of California - San Diego 12.14.20

    • Cardiovascular | Patient Monitoring
      FDA OKs Volta Medical

      FDA OKs Volta Medical's VX1 AI AFib Mapping Software

      Assists in real-time manual annotation of 3D anatomical, electrical maps of the atria during AFib.
      PR Newswire 12.10.20


    • Patient Monitoring | Software & IT
      AI Metrics

      AI Metrics' Liver Imaging Software Earns FDA Nod

      Early-stage startup approved for low-cost, low-risk, non-invasive procedures for chronic liver disease patients.
      University of Alabama at Birmingham 12.09.20

    • Chronic Disease | Patient Monitoring
      FDA OKs Baxter

      FDA OKs Baxter's Homechoice Claria with Sharesource

      Sharesource is a two-way remote patient management platform for patients on peritoneal dialysis.
      Business Wire 11.23.20

    • Patient Monitoring
      CE Mark Granted for Automated Glycemic Control and Continuous Diagnostics System

      CE Mark Granted for Automated Glycemic Control and Continuous Diagnostics System

      PrecisionOne provides automated glucose regulation and real-time analysis of blood chemistry values for critical care patients.
      PR Newswire 11.23.20


    Trending
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • 7 Considerations For Designing Medical Device Mechanisms
    • Common Issues And Their Solutions In Health Application Development
    Breaking News
    • Axonics Buys Contura to Expand to Stress Urinary Incontinence
    • Nurx Appoints Chief Medical Officer
    • Median Technologies, UC San Diego to Partner on AI-Based Medical Imaging Technology
    • Novel Heart Failure Treatment Technology Scores Positive Trial Results
    • New COVID-19 Saliva Test Also Can Detect Variants and Flu Viruses
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • Seeking a Revolution in Clinical Care Through AI
    • Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit
    • Addition by Subtraction: The Latest of Machining for Medtech
    • Innovation Incubators: An R&D Roundtable
    • Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Martin Bauer Group Acquires Majority Stake in Beverage Company Power Brands
    Gencor Announces Positive Results in VeriSperse Bioavailability Study
    PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC
    Coatings World

    Latest Breaking News From Coatings World

    Mule-Hide Products Co. Promotes Steven Litaker to Territory Manager
    Terra Firma, Wanhua Announce New Distribution Partnership
    Gelest CEO Elected to National Academy of Engineering
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Axonics Buys Contura to Expand to Stress Urinary Incontinence
    Nurx Appoints Chief Medical Officer
    Median Technologies, UC San Diego to Partner on AI-Based Medical Imaging Technology
    Contract Pharma

    Latest Breaking News From Contract Pharma

    J&J’s Single-Dose COVID-19 Vax Issued EUA
    Icon to Acquire PRA Health Sciences
    Phlow Corp. and USP Form Alliance
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Universal Engraving Announces New President
    Raw Sugar Living Expands to Target with New Collection
    Supporting Female Beauty Brand Founders on International Women's Day
    Happi

    Latest Breaking News From Happi

    ACI and CBC Launch Webpage About ‘Quats’
    L’Occitane Launches Hand Cream Inspired by Women
    Kiehl’s Partners with Gyrl Wonder
    Ink World

    Latest Breaking News From Ink World

    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Edale names SMAG Graphique distributor in France
    TLMI analyzes pandemic's effect on label industry in new report
    UEI names Ross Hutchison president
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    U.S. Nonwovens Rebrands as Radienz Living
    What You’re Reading on Nonwovens-Industry.com
    Texas Medical Technology Partners with My Protect Kit
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Pandemic Pain: NuVasive's 2020 Sales Fall 10 Percent
    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login